Regen BioPharma Inc (RGBP)

[29YEARINVESTOR]

Research programme: cancer therapeutics - Regen https://adisinsight.springer.com/drugs/800037634 drugs
This allows continual expression of mRNA-specific siRNA and direct inhibition of protein ... These data were published in two peer-reviewed articles in the ... google or
Spend the $50
notice the Latest Information Update: 15 Mar 2022 today!

Here is another google rgbp patents and peer review
NR2F6 Peer reviewed! Literature 1
Here is another google!
The invention is based on findings that leukemic stem cells, which are capable of giving rise to aggressive leukemias, contained high levels of the NR2F6 gene, whereas leukemic cells that are less aggressive and cannot give rise to disease lack this gene. Importantly, when the NR2F6 gene was silenced by shRNA in leukemic stem cells, the stem cells lost leukemia forming ability and turned into normal cells. Some of these data were published in the peer-reviewed literature1. Subsequently, it was discovered that the same gene target NR2F6 is also found in cancer stem cells in other types of tumors such as breast, lung, ovarian, and colon2.
Some want others to hand them DD on a silver platter, when anyone
That knows how to google anyone could do there own DD and be reading all day!